State-of-the-art strategies for targeting the DNA damage response in cancer

PG Pilié, C Tang, GB Mills, TA Yap - Nature reviews Clinical oncology, 2019 - nature.com
Genomic instability is a key hallmark of cancer that arises owing to defects in the DNA
damage response (DDR) and/or increased replication stress. These alterations promote the …

Cancer drug development: The missing links

AB Kunnumakkara, D Bordoloi… - Experimental …, 2019 - journals.sagepub.com
Although better science and technology has been linked with better health care, however,
reality is much different. Although America and most of Europe are equipped with most …

Systematic functional annotation of somatic mutations in cancer

PKS Ng, J Li, KJ Jeong, S Shao, H Chen, YH Tsang… - Cancer cell, 2018 - cell.com
The functional impact of the vast majority of cancer somatic mutations remains unknown,
representing a critical knowledge gap for implementing precision oncology. Here, we report …

CellBox: interpretable machine learning for perturbation biology with application to the design of cancer combination therapy

B Yuan, C Shen, A Luna, A Korkut, DS Marks… - Cell systems, 2021 - cell.com
Systematic perturbation of cells followed by comprehensive measurements of molecular and
phenotypic responses provides informative data resources for constructing computational …

Comprehensive characterization of protein–protein interactions perturbed by disease mutations

F Cheng, J Zhao, Y Wang, W Lu, Z Liu, Y Zhou… - Nature …, 2021 - nature.com
Technological and computational advances in genomics and interactomics have made it
possible to identify how disease mutations perturb protein–protein interaction (PPI) networks …

Impact of lineage plasticity to and from a neuroendocrine phenotype on progression and response in prostate and lung cancers

MA Rubin, RG Bristow, PD Thienger, C Dive… - Molecular cell, 2020 - cell.com
Intratumoral heterogeneity can occur via phenotype transitions, often after chronic exposure
to targeted anticancer agents. This process, termed lineage plasticity, is associated with …

[HTML][HTML] The emerging potential for network analysis to inform precision cancer medicine

K Ozturk, M Dow, DE Carlin, R Bejar… - Journal of molecular …, 2018 - Elsevier
Precision cancer medicine promises to tailor clinical decisions to patients using genomic
information. Indeed, successes of drugs targeting genetic alterations in tumors, such as …

FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators

J Lu, J Xu, J Li, T Pan, J Bai, L Wang, X Jin… - Nucleic acids …, 2018 - academic.oup.com
Epigenetic alterations, a well-recognized cancer hallmark, are driven by chromatin
regulators (CRs). However, little is known about the extent of CR deregulation in cancer, and …

A systems approach to clinical oncology uses deep phenotyping to deliver personalized care

JT Yurkovich, Q Tian, ND Price, L Hood - Nature Reviews Clinical …, 2020 - nature.com
Cancer encompasses a complex, heterogeneous and dynamic group of diseases that arise
from perturbations to multiple biological networks within the body. A systems biology-based …

Gain-of-function mutations: an emerging advantage for cancer biology

Y Li, Y Zhang, X Li, S Yi, J Xu - Trends in biochemical sciences, 2019 - cell.com
Advances in next-generation sequencing have identified thousands of genomic variants that
perturb the normal functions of proteins, further contributing to diverse phenotypic …